UPDATE: UBS Assumes Teva Pharma (TEVA) at Neutral
Tweet Send to a Friend
(Updated - June 13, 2022 4:52 PM EDT)
UBS analyst Ashwani Verma assumes coverage on Teva Pharma (NYSE: TEVA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Ashwani Verma assumes coverage on Teva Pharma (NYSE: TEVA) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
